<DOC>
	<DOC>NCT03101436</DOC>
	<brief_summary>In this study, the investigators will evaluate the prebiotic effect of a moderate intake of extra virgin olive oil or red wine on the modulation of gut microbiota composition and the improvement of cardiometabolic factors in obese and lean adults subjects.</brief_summary>
	<brief_title>Extra Virgin Olive Oil, Red Wine Polyphenols and Fecal Microbiota</brief_title>
	<detailed_description />
	<criteria>Obese patients (body mass index (BMI= or &gt; 30kg/m2) with high insulin resistance (measured by Homeostasis Model Assessment Insulin Resistance Index (HOMAIR) &gt; 5.5. Lean subjects (BMI&lt; 28kg/m2) with low insulin resistance (HOMAIR&lt; 3.3). Exclusion Criteria (all patients): Type 2 diabetes Acute or chronic infection Inflammatory disease or endocrine disorders. History of cancer. Antiinflammatory, corticosteroid, hormone, or antibiotic drug treatment A history of alcohol abuse or drug dependence A restrictive diet or a weight change â‰¥5 kg during the 3 months prior to the study. Intake of prebiotics, probiotics, vitamin supplements or any other medical treatment influencing intestinal microbiota during the 3 months before the start of the study or during the study.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Insulin Resistance</keyword>
	<keyword>Extra Virgin Olive Oil</keyword>
	<keyword>Red Wine</keyword>
	<keyword>Diet</keyword>
	<keyword>Microbiota</keyword>
</DOC>